INFLUENCE OF CpG ODN 2006 OLIGODEOXYNUCLEOTIDE ON CYTOKINE PRODUCTION BY BLOOD CELLS OF HUMANS VACCINATED AGAINST PLAGUE
This study presents data upon the effects of CpG oligonucleotide substance (CpG ODN 2006). The commercial preparation was applied in vitro as a single agent, or in combination with various cytokine production inducers. Spontaneous and induced cytokine levels were tested in cultures of human blood ce...
Guardado en:
Autores principales: | S. N. Klyueva, T. P. Shmelkova, T. N. Schukovskaya |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2f70e24f59f3496e92f5e4888e657b67 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
por: Hanagata N
Publicado: (2017) -
Effects of CpG oligodeoxynucleotide 1826 on acute radiation-induced lung injury in mice
por: Li,Xuan, et al.
Publicado: (2016) -
CpG Oligodeoxynucleotides Attenuate OVA-Induced Allergic Airway Inflammation via Suppressing JNK-Mediated Endoplasmic Reticulum Stress
por: Zhang HY, et al.
Publicado: (2021) -
Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice
por: Zhao Y, et al.
Publicado: (2020) -
Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice [Corrigendum]
por: Zhao Y, et al.
Publicado: (2021)